TREA

90647331

Follow

Information

  • Trademark
  • 90647331
  • Serial Number
    90647331
  • Registration Number
    6816378
  • Filing Date
    April 15, 2021
    3 years ago
  • Registration Date
    August 09, 2022
    2 years ago
  • Transaction Date
    March 27, 2023
    a year ago
  • Status Date
    August 09, 2022
    2 years ago
  • Published for Opposition Date
    October 19, 2021
    3 years ago
  • Location Date
    July 07, 2022
    2 years ago
  • First Use Anywhere Date
    September 20, 2021
    3 years ago
  • First Use In Commerce Date
    September 20, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    KETCHUM, BRENDAN J
  • Attorney Docket Number
    140679539565
    Attorney Name
    Kristen S. Ruisi
    Law Office Assigned Location Code
    N70
  • Owners
Information
Mark Drawing Code
2000
Case File Statements
  • GS0401: Custom manufacturing services in the nature of chemical processing and production of medicines and pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
  • DM0000: The mark consists of a shaded square in red with a stylized square and a star in the center of the stylized square.
  • GS0051: Pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemico-pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; drugs in the nature of pharmaceutical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for pharmaceutical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; medicines for human purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical preparations for medical purposes for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; crude drugs in the nature of pharmaceutical preparations for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Biochemical preparations for medical use for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases
  • CC0000: The color(s) red is/are claimed as a feature of the mark.
  • GS0441: Telemedicine services; health care; convalescent home services; physical therapy services; health counseling; pharmacy advice, namely, pharmaceutical advice
  • GS0421: Research and development of new products for others; technological research in the field of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical research; conducting clinical trials for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological research; quality control for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; electronic data storage; material testing; cloud computing featuring software for use in database management, word processing, spreadsheet management, tracking; packaging design
Case File Event Statements
  • 3/24/2023 - a year ago
    28 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 3/24/2023 - a year ago
    27 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 3/24/2023 - a year ago
    26 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 12/8/2022 - a year ago
    25 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 12/8/2022 - a year ago
    24 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 12/8/2022 - a year ago
    23 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 12/8/2022 - a year ago
    22 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 12/8/2022 - a year ago
    21 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 8/9/2022 - 2 years ago
    20 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 8/9/2022 - 2 years ago
    19 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 7/8/2022 - 2 years ago
    18 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 7/7/2022 - 2 years ago
    17 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 6/1/2022 - 2 years ago
    16 - DATA MODIFICATION COMPLETED Type: DMCC
  • 6/1/2022 - 2 years ago
    15 - ASSIGNED TO LIE Type: ALIE
  • 5/26/2022 - 2 years ago
    14 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 5/12/2022 - 2 years ago
    13 - USE AMENDMENT FILED Type: IUAF
  • 5/26/2022 - 2 years ago
    12 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 5/26/2022 - 2 years ago
    11 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 5/12/2022 - 2 years ago
    10 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 12/14/2021 - 2 years ago
    9 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 10/19/2021 - 3 years ago
    8 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/19/2021 - 3 years ago
    7 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/29/2021 - 3 years ago
    6 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/13/2021 - 3 years ago
    5 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/8/2021 - 3 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/23/2021 - 3 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 7/22/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/19/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP